Reference is made to the announcement made on27 October 2023 regarding the transfer of 1,900,219 shares inMedistim ASA from Aeternum Capital AS to its 100% owned subsidiary, Acapital MEDI HoldCo AS ("HoldCo "), by way of a capital contribution in kind. As part of requests for in-specie redemption in Aeternum Capital AS by certain of its investors, a capital reduction in Aeternum Capital AS has been resolved by way of a distribution in kind of 8,154,977 shares inHoldCo from Aeternum Capital AS to the investors which have requested redemption, equal to approx. 81.55% of the votes and capital inHoldCo . The creditor notice period for such capital reduction expired today. The transfer of the shares inHoldCo will occur upon registration of the capital reduction with the Norwegian Business Registry, expected to occur in early 2024. As part of the redemption, 7,980,813 shares inHoldCo are distributed from Aeternum Capital AS toWQZ Investment Group Ltd. , equal to approx. 79.81% of the votes and capital inHoldCo . Following the transfer of the shares inHoldCo ,WQZ Investment Group Ltd. will be the majority shareholder with controlling voting rights inHoldCo and will be the indirect holder of the 1,900,219 shares inMedistim ASA , equal to approx. 10.36% of the shares and votes inMedistim ASA . Aeternum Capital AS and other companies managed by Aeternum Management AS will be a minority shareholder inHoldCo and will as such no longer have indirect control over the shares held byHoldCo inMedistim ASA . Aeternum Capital AS is managed by Aeternum Management AS, whileWQZ Investment Group Ltd. is indirectly controlled by trusts established byJohn Fredriksen for the benefit of his family. No other rights to shares inMedistim ASA are held directly or indirectly by any of the above mentioned entities. Aeternum Capital AS is a closely associated person ofAnthea Arff-Pettersen , board member and primary insider inMedistim ASA . Please see attached form for further details. This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and Sections 4-2, cf. 5-12 of the Norwegian Securities Trading Act.
Click here for more information
© Oslo Bors ASA, source